Cargando…

Noncovalent hyaluronan crosslinking by TSG-6: Modulation by heparin, heparan sulfate, and PRG4

The size, conformation, and organization of the glycosaminoglycan hyaluronan (HA) affect its interactions with soluble and cell surface-bound proteins. HA that is induced to form stable networks has unique biological properties relative to unmodified soluble HA. AlphaLISA assay technology offers a f...

Descripción completa

Detalles Bibliográficos
Autores principales: Sin, Yun Jin Ashley, MacLeod, Rebecca, Tanguay, Adam P., Wang, Andrew, Braender-Carr, Olivia, Vitelli, Teraesa M., Jay, Gregory D., Schmidt, Tannin A., Cowman, Mary K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579337/
https://www.ncbi.nlm.nih.gov/pubmed/36275631
http://dx.doi.org/10.3389/fmolb.2022.990861
_version_ 1784812158999068672
author Sin, Yun Jin Ashley
MacLeod, Rebecca
Tanguay, Adam P.
Wang, Andrew
Braender-Carr, Olivia
Vitelli, Teraesa M.
Jay, Gregory D.
Schmidt, Tannin A.
Cowman, Mary K.
author_facet Sin, Yun Jin Ashley
MacLeod, Rebecca
Tanguay, Adam P.
Wang, Andrew
Braender-Carr, Olivia
Vitelli, Teraesa M.
Jay, Gregory D.
Schmidt, Tannin A.
Cowman, Mary K.
author_sort Sin, Yun Jin Ashley
collection PubMed
description The size, conformation, and organization of the glycosaminoglycan hyaluronan (HA) affect its interactions with soluble and cell surface-bound proteins. HA that is induced to form stable networks has unique biological properties relative to unmodified soluble HA. AlphaLISA assay technology offers a facile and general experimental approach to assay protein-mediated networking of HA in solution. Connections formed between two end-biotinylated 50 kDa HA (bHA) chains can be detected by signal arising from streptavidin-coated donor and acceptor beads being brought into close proximity when the bHA chains are bridged by proteins. We observed that incubation of bHA with the protein TSG-6 (tumor necrosis factor alpha stimulated gene/protein 6, TNFAIP/TSG-6) leads to dimerization or higher order multimerization of HA chains in solution. We compared two different heparin (HP) samples and two heparan sulfate (HS) samples for the ability to disrupt HA crosslinking by TSG-6. Both HP samples had approximately three sulfates per disaccharide, and both were effective in inhibiting HA crosslinking by TSG-6. HS with a relatively high degree of sulfation (1.75 per disaccharide) also inhibited TSG-6 mediated HA networking, while HS with a lower degree of sulfation (0.75 per disaccharide) was less effective. We further identified Proteoglycan 4 (PRG4, lubricin) as a TSG-6 ligand, and found it to inhibit TSG-6-mediated HA crosslinking. The effects of HP, HS, and PRG4 on HA crosslinking by TSG-6 were shown to be due to HP/HS/PRG4 inhibition of HA binding to the Link domain of TSG-6. Using the AlphaLISA platform, we also tested other HA-binding proteins for ability to create HA networks. The G1 domain of versican (VG1) effectively networked bHA in solution but required a higher concentration than TSG-6. Cartilage link protein (HAPLN1) and the HA binding protein segment of aggrecan (HABP, G1-IGD-G2) showed only low and variable magnitude HA networking effects. This study unambiguously demonstrates HA crosslinking in solution by TSG-6 and VG1 proteins, and establishes PRG4, HP and highly sulfated HS as modulators of TSG-6 mediated HA crosslinking.
format Online
Article
Text
id pubmed-9579337
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95793372022-10-20 Noncovalent hyaluronan crosslinking by TSG-6: Modulation by heparin, heparan sulfate, and PRG4 Sin, Yun Jin Ashley MacLeod, Rebecca Tanguay, Adam P. Wang, Andrew Braender-Carr, Olivia Vitelli, Teraesa M. Jay, Gregory D. Schmidt, Tannin A. Cowman, Mary K. Front Mol Biosci Molecular Biosciences The size, conformation, and organization of the glycosaminoglycan hyaluronan (HA) affect its interactions with soluble and cell surface-bound proteins. HA that is induced to form stable networks has unique biological properties relative to unmodified soluble HA. AlphaLISA assay technology offers a facile and general experimental approach to assay protein-mediated networking of HA in solution. Connections formed between two end-biotinylated 50 kDa HA (bHA) chains can be detected by signal arising from streptavidin-coated donor and acceptor beads being brought into close proximity when the bHA chains are bridged by proteins. We observed that incubation of bHA with the protein TSG-6 (tumor necrosis factor alpha stimulated gene/protein 6, TNFAIP/TSG-6) leads to dimerization or higher order multimerization of HA chains in solution. We compared two different heparin (HP) samples and two heparan sulfate (HS) samples for the ability to disrupt HA crosslinking by TSG-6. Both HP samples had approximately three sulfates per disaccharide, and both were effective in inhibiting HA crosslinking by TSG-6. HS with a relatively high degree of sulfation (1.75 per disaccharide) also inhibited TSG-6 mediated HA networking, while HS with a lower degree of sulfation (0.75 per disaccharide) was less effective. We further identified Proteoglycan 4 (PRG4, lubricin) as a TSG-6 ligand, and found it to inhibit TSG-6-mediated HA crosslinking. The effects of HP, HS, and PRG4 on HA crosslinking by TSG-6 were shown to be due to HP/HS/PRG4 inhibition of HA binding to the Link domain of TSG-6. Using the AlphaLISA platform, we also tested other HA-binding proteins for ability to create HA networks. The G1 domain of versican (VG1) effectively networked bHA in solution but required a higher concentration than TSG-6. Cartilage link protein (HAPLN1) and the HA binding protein segment of aggrecan (HABP, G1-IGD-G2) showed only low and variable magnitude HA networking effects. This study unambiguously demonstrates HA crosslinking in solution by TSG-6 and VG1 proteins, and establishes PRG4, HP and highly sulfated HS as modulators of TSG-6 mediated HA crosslinking. Frontiers Media S.A. 2022-10-05 /pmc/articles/PMC9579337/ /pubmed/36275631 http://dx.doi.org/10.3389/fmolb.2022.990861 Text en Copyright © 2022 Sin, MacLeod, Tanguay, Wang, Braender-Carr, Vitelli, Jay, Schmidt and Cowman. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Biosciences
Sin, Yun Jin Ashley
MacLeod, Rebecca
Tanguay, Adam P.
Wang, Andrew
Braender-Carr, Olivia
Vitelli, Teraesa M.
Jay, Gregory D.
Schmidt, Tannin A.
Cowman, Mary K.
Noncovalent hyaluronan crosslinking by TSG-6: Modulation by heparin, heparan sulfate, and PRG4
title Noncovalent hyaluronan crosslinking by TSG-6: Modulation by heparin, heparan sulfate, and PRG4
title_full Noncovalent hyaluronan crosslinking by TSG-6: Modulation by heparin, heparan sulfate, and PRG4
title_fullStr Noncovalent hyaluronan crosslinking by TSG-6: Modulation by heparin, heparan sulfate, and PRG4
title_full_unstemmed Noncovalent hyaluronan crosslinking by TSG-6: Modulation by heparin, heparan sulfate, and PRG4
title_short Noncovalent hyaluronan crosslinking by TSG-6: Modulation by heparin, heparan sulfate, and PRG4
title_sort noncovalent hyaluronan crosslinking by tsg-6: modulation by heparin, heparan sulfate, and prg4
topic Molecular Biosciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579337/
https://www.ncbi.nlm.nih.gov/pubmed/36275631
http://dx.doi.org/10.3389/fmolb.2022.990861
work_keys_str_mv AT sinyunjinashley noncovalenthyaluronancrosslinkingbytsg6modulationbyheparinheparansulfateandprg4
AT macleodrebecca noncovalenthyaluronancrosslinkingbytsg6modulationbyheparinheparansulfateandprg4
AT tanguayadamp noncovalenthyaluronancrosslinkingbytsg6modulationbyheparinheparansulfateandprg4
AT wangandrew noncovalenthyaluronancrosslinkingbytsg6modulationbyheparinheparansulfateandprg4
AT braendercarrolivia noncovalenthyaluronancrosslinkingbytsg6modulationbyheparinheparansulfateandprg4
AT vitelliteraesam noncovalenthyaluronancrosslinkingbytsg6modulationbyheparinheparansulfateandprg4
AT jaygregoryd noncovalenthyaluronancrosslinkingbytsg6modulationbyheparinheparansulfateandprg4
AT schmidttannina noncovalenthyaluronancrosslinkingbytsg6modulationbyheparinheparansulfateandprg4
AT cowmanmaryk noncovalenthyaluronancrosslinkingbytsg6modulationbyheparinheparansulfateandprg4